Russell Petty

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

Susan Dutton, David Ferry, Jane Blazeby et al. · The Lancet Oncology · 2014 · 329 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Medicine +6

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo et al. · The Lancet Oncology · 2019 · 276 citations · Full text

First-line Therapy, Gastrointestinal Oncology, Medicine +6

Comparison of MTT and ATP‐based assays for the measurement of viable cell number

Russell Petty, Lesley Sutherland, Elizabeth M. Hunter et al. · Journal of Bioluminescence and Chemiluminescence · 1995 · 240 citations

A Deep Learning Framework for Predicting Response to Therapy in Cancer

Theodore Sakellaropoulos, Konstantinos Vougas, Sonali Narang et al. · Cell Reports · 2019 · 209 citations · Full text

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

Eric Van Cutsem, Yu Jeong Bang, Wasat Mansoor et al. · Annals of Oncology · 2017 · 183 citations · Full text

Gene Amplification, Gastrointestinal Oncology, Medicine +6